Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biogen Inc (BIIB)

Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 28,490,324
  • Shares Outstanding, K 146,759
  • Annual Sales, $ 9,891 M
  • Annual Income, $ 1,293 M
  • EBIT $ 2,377 M
  • EBITDA $ 3,451 M
  • 60-Month Beta 0.16
  • Price/Sales 2.90
  • Price/Cash Flow 8.64
  • Price/Book 1.57

Options Overview Details

View History
  • Implied Volatility 32.02% (+1.23%)
  • Historical Volatility 41.38%
  • IV Percentile 18%
  • IV Rank 11.99%
  • IV High 64.86% on 04/09/25
  • IV Low 27.55% on 01/07/26
  • Expected Move (DTE 8) 6.29 (3.27%)
  • Put/Call Vol Ratio 0.09
  • Today's Volume 1,209
  • Volume Avg (30-Day) 1,884
  • Put/Call OI Ratio 0.76
  • Today's Open Interest 52,792
  • Open Int (30-Day) 51,029
  • Expected Range 185.79 to 198.37

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 34 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 3.07
  • Number of Estimates 26
  • High Estimate 4.68
  • Low Estimate 1.66
  • Prior Year 3.02
  • Growth Rate Est. (year over year) +1.66%

Price Performance

See More
Period Period Low Period High Performance
1-Month
160.36 +19.78%
on 01/20/26
202.41 -5.10%
on 02/06/26
+27.66 (+16.82%)
since 01/16/26
3-Month
160.36 +19.78%
on 01/20/26
202.41 -5.10%
on 02/06/26
+24.15 (+14.38%)
since 11/19/25
52-Week
110.04 +74.55%
on 04/09/25
202.41 -5.10%
on 02/06/26
+55.40 (+40.53%)
since 02/19/25

Most Recent Stories

More News
3 Value Stocks Walking a Fine Line

3 Value Stocks Walking a Fine Line

PANL : 9.03 (+1.12%)
WEX : 154.72 (-2.69%)
BIIB : 192.08 (-1.06%)
What Are Wall Street Analysts' Target Price for Biogen Stock?

Analysts are maintaining a generally positive outlook on Biogen's shares, noting recent stock strength and solid operational results.

$SPX : 6,861.89 (-0.28%)
IBB : 175.03 (+0.15%)
BIIB : 192.08 (-1.06%)
The 5 Most Interesting Analyst Questions From Biogen’s Q4 Earnings Call

The 5 Most Interesting Analyst Questions From Biogen’s Q4 Earnings Call

BIIB : 192.08 (-1.06%)
1 Unpopular Stock That Deserves a Second Chance and 2 We Find Risky

1 Unpopular Stock That Deserves a Second Chance and 2 We Find Risky

ASGN : 44.49 (+3.18%)
ALHC : 20.84 (+1.61%)
BIIB : 192.08 (-1.06%)
Biogen Announces Board Chair Transition

CAMBRIDGE, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Biogen Inc . (Nasdaq: BIIB) today announced that the Board of Directors has elected Dr. Maria C. Freire as Chair of the Board of Directors, effective...

BIIB : 192.08 (-1.06%)
BIIB Q4 Deep Dive: Pipeline Advances and New Product Launches Offset Legacy Headwinds

BIIB Q4 Deep Dive: Pipeline Advances and New Product Launches Offset Legacy Headwinds

BIIB : 192.08 (-1.06%)
Biogen’s (NASDAQ:BIIB) Q4 CY2025: Strong Sales

Biogen’s (NASDAQ:BIIB) Q4 CY2025: Strong Sales

BIIB : 192.08 (-1.06%)
Stock Index Futures Climb After Tech Rout, Amazon Slips on CapEx Blowout

March S&P 500 E-Mini futures (ESH26) are up +0.58%, and March Nasdaq 100 E-Mini futures (NQH26) are up +0.69% this morning, rebounding after days of heavy selling as investors stepped in to buy the dip....

MARA : 7.96 (+6.13%)
MSTR : 129.45 (+3.39%)
NVDA : 187.90 (-0.04%)
AVGO : 333.99 (+0.14%)
BE : 159.00 (+1.10%)
KOG.O.DX : 393.000 (-0.97%)
MOH : 148.24 (+3.95%)
STLAP.FP : 6.418 (-4.37%)
MU : 417.35 (-0.86%)
ESH26 : 6,886.75 (+0.14%)
MSFT : 398.46 (-0.29%)
NOVOB.C.DX : 305.950 (-1.64%)
Biogen (BIIB) Reports Q4: Everything You Need To Know Ahead Of Earnings

Biogen (BIIB) Reports Q4: Everything You Need To Know Ahead Of Earnings

BIIB : 192.08 (-1.06%)
Stoke Therapeutics to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine,...

STOK : 34.37 (+10.94%)
BIIB : 192.08 (-1.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Biogen Inc. is one of the world's leading biotechnology companies which focuses on developing innovative therapies for treating serious neurological and neurodegenerative diseases, including its core growth areas of multiple sclerosis (MS) and neuroimmunology, Alzheimer's disease (AD) and dementia, movement...

See More

Key Turning Points

3rd Resistance Point 198.30
2nd Resistance Point 196.65
1st Resistance Point 194.36
Last Price 192.08
1st Support Level 190.42
2nd Support Level 188.77
3rd Support Level 186.48

See More

52-Week High 202.41
Last Price 192.08
Fibonacci 61.8% 167.12
Fibonacci 50% 156.23
Fibonacci 38.2% 145.33
52-Week Low 110.04

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar